Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
$0.00
$0.00
$0.02
N/A3.99450 shsN/A
LCIN
Lannett
$0.02
$0.01
$0.02
$160K0.92475,780 shs441,200 shs
Q Biomed Inc. stock logo
QBIO
Q Biomed
$0.00
+∞
$0.00
$0.00
$0.03
N/A2.225,937 shs1,100 shs
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
$0.00
$0.00
$0.00
$0.00
$90K4.97N/AN/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
0.00%0.00%0.00%0.00%-98.40%
LCIN
Lannett
0.00%0.00%0.00%0.00%0.00%
Q Biomed Inc. stock logo
QBIO
Q Biomed
0.00%0.00%0.00%-50.00%0.00%
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
0.00%0.00%0.00%+450.00%+10.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
LCIN
Lannett
N/AN/AN/AN/AN/AN/AN/AN/A
Q Biomed Inc. stock logo
QBIO
Q Biomed
N/AN/AN/AN/AN/AN/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
0.00
N/AN/AN/A
LCIN
Lannett
0.00
N/AN/AN/A
Q Biomed Inc. stock logo
QBIO
Q Biomed
0.00
N/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
N/AN/AN/AN/AN/AN/A
LCIN
Lannett
$340.58M0.00N/AN/A($23.34) per share0.00
Q Biomed Inc. stock logo
QBIO
Q Biomed
$280KN/AN/AN/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
$660K0.12N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
-$2.11MN/A0.00N/AN/AN/AN/AN/AN/A
LCIN
Lannett
-$231.62M-$18.88N/AN/AN/A-62.40%N/A-13.39%N/A
Q Biomed Inc. stock logo
QBIO
Q Biomed
-$2.05MN/A0.00N/AN/AN/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
-$750KN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
N/AN/AN/AN/AN/A
LCIN
Lannett
N/AN/AN/AN/AN/A
Q Biomed Inc. stock logo
QBIO
Q Biomed
N/AN/AN/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
N/AN/AN/A
LCIN
Lannett
N/A
2.23
1.39
Q Biomed Inc. stock logo
QBIO
Q Biomed
N/AN/AN/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
N/A
LCIN
Lannett
40.28%
Q Biomed Inc. stock logo
QBIO
Q Biomed
N/A
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
0.01%

Insider Ownership

CompanyInsider Ownership
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
28.20%
LCIN
Lannett
13.12%
Q Biomed Inc. stock logo
QBIO
Q Biomed
28.20%
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
15.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Adhera Therapeutics, Inc. stock logo
ATRX
Adhera Therapeutics
211.63 million8.35 millionNot Optionable
LCIN
Lannett
N/A10.49 million9.35 millionOptionable
Q Biomed Inc. stock logo
QBIO
Q Biomed
3N/AN/ANot Optionable
Wellness Center Usa Inc. stock logo
WCUI
Wellness Center Usa
8143.19 million120.71 millionNot Optionable

Recent News About These Companies

Cancer Wellness Center of NEPA holds Annual Walk
Wellness Center attendance up
MCCTC Plans New Health and Wellness Center
Chamber holds ribbon cutting for Women’s Wellness Center

New MarketBeat Followers Over Time

Media Sentiment Over Time

Adhera Therapeutics stock logo

Adhera Therapeutics OTCMKTS:ATRX

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Lannett NYSE:LCIN

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Q Biomed stock logo

Q Biomed OTCMKTS:QBIO

$0.0001 +0.00 (+∞)
As of 03:50 PM Eastern

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

Wellness Center Usa stock logo

Wellness Center Usa OTCMKTS:WCUI

$0.0006 0.00 (0.00%)
As of 06/24/2025

Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.